Ferumoxytol Levels and Effects while Breastfeeding
Summary of Use during Lactation
No information is available on the use of ferumoxytol during breastfeeding; however, the drug has been given safely to neonates intravenously as a magnetic resonance contrast agent.[1] An alternate intravenous iron product with more published data on breastfeeding available may be preferred. For additional information on iron use during breastfeeding, see the monograph on Iron Salts.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Little JT, Bookwalter CA. Magnetic resonance safety: Pregnancy and lactation. Magn Reson Imaging Clin N Am 2020;28:509-16. [PubMed: 33040992]
Substance Identification
Substance Name
Ferumoxytol
CAS Registry Number
722492-56-0
Drug Class
Breast Feeding
Lactation
Milk, Human
Contrast Media
Ferric Compounds
Hematinics
Iron Compounds
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
